Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Open, Randomized, Dose Finding Phase II Study to Investigate Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) Releasing Different Amounts of Levonorgestrel Compared to MIRENA in Nulliparous and Parous Women in Need of Contraception.

NCT00185380 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00185380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Open, Randomized, Dose Finding Phase II Study to Investigate Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) Releasing Different Amounts of Levonorgestrel Compared to MIRENA in Nulliparous and Parous Women in Need of Contraception.
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
December 31, 2008
Enrollment
742 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

contraception